Using Oncolytic Viruses to Target TGF-β in the Tumor Microenvironment
Time: 3:00 pm
day: Conference Day Two
Details:
- Directly targeting tumors using OVs to avoid systematic toxicity for better patient response
- Targeting the TGF-β receptors with oncolytic viruses for strong immune response
- Uncovering preclinical success using OVs to show clinical efficacy
New Data!
